Self-Efficacy Targeted Treatments for Weight Loss in Postmenopausal Women

K. E. Dennis,N. Tomoyasu,S. McCrone,A. Goldberg,L. Bunyard,Bing Bing Qi

DOI: https://doi.org/10.1891/0889-7182.15.3.259

2001-01-01

Research and Theory for Nursing Practice

Abstract:

What problem does this paper attempt to address?

Self-regulatory and self-efficacy mechanisms of weight loss in women within a community-based behavioral obesity treatment

James J. Annesi,Francine A. Stewart

DOI: https://doi.org/10.1007/s10865-024-00494-2

2024-05-20

Journal of Behavioral Medicine

Abstract:Given the traditional methods of treating obesity through education on controlling eating and increasing exercise have largely failed beyond the very short term, a more intensive focus on psychosocial correlates of those weight-loss behaviors has been suggested. Multiple behavioral theories incorporate self-regulation, self-efficacy, and mood; however, their interrelations and effects over both the short and long term within cognitive-behavioral obesity treatments remain unclear. Within a novel community-based program with women with obesity who had either low ( n = 29) or high ( n = 71) mood disturbance scores, there were significant improvements in exercise- and eating-related self-regulation and eating-related self-efficacy—primary targets of that intervention—with no significant difference in those changes by mood disturbance grouping. Changes in the summed exercise- and eating-related self-regulation scores significantly mediated relationships between changes in eating-related self-efficacy and weight (over both 6 and 12 months). There were similar results with mediation assessed via the extent exercise-related self-regulation carried over to eating-related self-regulation. In both of those models a reciprocal relationship between self-regulation and self-efficacy changes was indicated. In serial multiple mediation equations, paths of changes in exercise-related self-regulation → eating-related self-regulation → eating-related self-efficacy → weight were significant. However, paths were not significant when change in self-efficacy was entered as the predictor (initial) variable. Findings suggest viability in first focusing on exercise-related self-regulation, then eating-related self-regulation, in the course of increasing self-efficacy and probabilities for inducing enough sustained weight loss to improve obesity-associated health risks. Benefits of field-based research findings generalizing to weight-management applications were suggested.

psychology, clinical
Weight Loss and the Prevention of Weight Regain: Evaluation of a Treatment Model of Exercise Self-Regulation Generalizing to Controlled Eating

James J Annesi,Ping H Johnson,Gisèle A Tennant,Kandice J Porter,Kristin L Mcewen

DOI: https://doi.org/10.7812/TPP/15-146

Abstract:Context: For decades, behavioral weight-loss treatments have been unsuccessful beyond the short term. Development and testing of innovative, theoretically based methods that depart from current failed practices is a priority for behavioral medicine. Objective: To evaluate a new, theory-based protocol in which exercise support methods are employed to facilitate improvements in psychosocial predictors of controlled eating and sustained weight loss. Methods: Women with obesity were randomized into either a comparison treatment that incorporated a print manual plus telephone follow-ups (n = 55) or an experimental treatment of The Coach Approach exercise-support protocol followed after 2 months by group nutrition sessions focused on generalizing self-regulatory skills from an exercise support to a controlled eating context (n = 55). Repeated-measures analysis of variance contrasted group changes in weight, physical activity, fruit and vegetable intake, mood, and exercise- and eating-related self-regulation and self-efficacy over 24 months. Regression analyses determined salient interrelations of change scores over both the weight-loss phase (baseline-month 6) and weight-loss maintenance phase (month 6-month 24). Results: Improvements in all psychological measures, physical activity, and fruit and vegetable intake were significantly greater in the experimental group where a mean weight loss of 5.7 kg (6.1% of initial body weight) occurred at month 6, and was largely maintained at a loss of 5.1 kg (5.4%) through the full 24 months of the study. After establishing temporal intervals for changes in self-regulation, self-efficacy, and mood that best predicted improvements in physical activity and eating, a consolidated multiple mediation model suggested that change in self-regulation best predicted weight loss, whereas change in self-efficacy best predicted maintenance of lost weight. Conclusions: Because for most participants loss of weight remained greater than that required for health benefits, and costs for treatment administration were comparatively low, the experimental protocol was considered successful. After sufficient replication, physician referral and applications within health promotion and wellness settings should be considered.
Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

H. Krontiras,G. Colditz,T. Byers,K. Wolin,C. Rock,M. Naughton,B. Parker,R. Sedjo,B. Pakiz,Anthony D Elias,W. Demark-Wahnefried,S. Flatt,Jingxia Liu,P. Ganz,H. Wyatt

DOI: https://doi.org/10.1200/JCO.2015.61.1095

IF: 45.3

2015-08-17

Journal of Clinical Oncology

Abstract:PURPOSE Obesity increases risk for all-cause and breast cancer mortality and comorbidities in women who have been diagnosed and treated for breast cancer. The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study is the largest weight loss intervention trial among survivors of breast cancer to date. METHODS In this multicenter trial, 692 overweight/obese women who were, on average, 2 years since primary treatment for early-stage breast cancer were randomly assigned to either a group-based behavioral intervention, supplemented with telephone counseling and tailored newsletters, to support weight loss or a less intensive control intervention and observed for 2 years. Weight and blood pressure were measured at 6, 12, 18, and 24 months. Longitudinal mixed models were used to analyze change over time. RESULTS At 12 months, mean weight loss was 6.0% of initial weight in the intervention group and 1.5% in the control group (P<.001). At 24 months, mean weight loss in the intervention and control groups was 3.7% and 1.3%, respectively (P<.001). Favorable effects of the intervention on physical activity and blood pressure were observed. The weight loss intervention was more effective among women older than 55 years than among younger women. CONCLUSION A behavioral weight loss intervention can lead to clinically meaningful weight loss in overweight/obese survivors of breast cancer. These findings support the need to conduct additional studies to test methods that support sustained weight loss and to examine the potential benefit of intentional weight loss on breast cancer recurrence and survival.

Medicine
Pharmacologic Therapy To Induce Weight Loss In Women Who Have Obesity/Overweight With Polycystic Ovary Syndrome: A Systematic Review And Network Meta-Analysis

F-F Wang,Y Wu,Y-H Zhu,T Ding,R L Batterham,F Qu,P J Hardiman

DOI: https://doi.org/10.1111/obr.12720

IF: 10.867

2018-01-01

Obesity Reviews

Abstract:Background: Women with polycystic ovary syndrome (PCOS) are almost three times more likely to be obese than those without PCOS. However, we have no specific interventions to induce weight loss so far and rely on drugs used to treat other symptoms of the syndrome or obesity in the general population.Objective: The objective of this study is to compare the effectiveness of metformin, inositol, liraglutide and orlistat to induce weight loss in women with PCOS and overweight/obesity.Methods: A search was conducted using the MEDLINE, EMBASE, PubMed and CENTRAL databases. Individually randomized, parallel group trials that evaluated the effects of these pharmacological treatments among adults or adolescents with PCOS and overweight/obesity, compared with a placebo or metformin group, were considered eligible. Registration number: PROSPERO CRD 42017076625.Results: Twenty-three trials reporting on 941 women were included in the network meta-analysis. The amount of weight lost differed significantly among the drugs (in descending order): liraglutide, orlistat and metformin. Liraglutide alone, liraglutide/metformin and metformin alone significantly reduced waist circumference, but no change was found with orlistat. Data for waist-to-hip ratio were only available for metformin, which had no significant effect.Conclusion: Liraglutide appears superior to the other drugs in reducing weight and waist circumference.
Evaluating the effect of targeting body shape concerns on long-term weight change

KayLoni L Olson,Tyler T Thaxton,Jacob D Landers,Charles F Emery

DOI: https://doi.org/10.1002/eat.24096

Abstract:Objective: The goal of this follow-up to a randomized proof-of-concept study was to determine if targeting body shape concern (BSC) has a clinically significant impact on long-term weight change among adult women of higher body weight with BSC. A secondary aim was to observe the maintenance of body image improvements during follow-up. Method: In the original 4-week trial, women were randomized to behavioral weight loss recommendations alone (control; n = 15) or combined with the evidence-based body project intervention (n = 17). All participants were directed to continue monitoring diet and exercise through Week 8. The current analysis focused on follow-up data collected on weight, BSC, internalized weight bias, internalized thin ideal, and body appreciation at 8 weeks, 6 months, and 12 months. Percent weight change was calculated from baseline and compared against clinical milestones of -2.5% and -5%. An intent-to-treat approach was used for individuals lost to follow-up (n = 11). Results: Body project participants achieved the clinically significant target of -2.5% weight loss by 12 months. Control participants did not reach the milestone and regained lost weight at 12 months. Neither condition reached the 5% clinical target. Both groups experienced improved body image, but body project participants maintained a greater magnitude of improvement in all measures except internalized thin ideal at 12 months. Conclusion: The current study provides preliminary evidence that targeting BSC among women with BSC who want to lose weight may improve long-term weight loss. Further intervention development and testing are warranted. Public significance: The results of this study suggest that targeting negative body image among adult women with high BSC might be a pathway to improve long-term weight loss in behavioral weight management. This is aligned with precision medicine priorities to optimize weight-related health care.
A body image and disordered eating intervention for women in midlife: A randomized controlled trial.

Siân A. McLean,Susan J. Paxton,Eleanor H. Wertheim

DOI: https://doi.org/10.1037/a0026094

2011-12-01

Journal of Consulting and Clinical Psychology

Abstract:OBJECTIVE: This study examined the outcome of a body image and disordered eating intervention for midlife women. The intervention was specifically designed to address risk factors that are pertinent in midlife.METHOD: Participants were 61 women aged 30 to 60 years (M = 43.92, SD = 8.22) randomly assigned to intervention (n = 32) or (delayed treatment) control (n = 29) groups. Following an 8-session facilitated group cognitive behavioral therapy-based intervention, outcomes from the Body Shape Questionnaire; Eating Disorder Examination Questionnaire; Body Image Avoidance Questionnaire; Physical Appearance Comparison Scale; Sociocultural Attitudes Towards Appearance Scale, Internalization subscale; measures of appearance importance, cognitive reappraisal, and self-care; Dutch Eating Behavior Questionnaire; and Kessler Psychological Distress Scale were compared for statistical and clinical significance from baseline to posttest and 6-month follow-up.RESULTS: Following the intent-to-treat principle, mixed-model analyses with a mixed within-between design demonstrated that the intervention group had large improvements that were statistically significantly different from the control group in body image, disordered eating, and risk factor variables and that were maintained at 6-month follow-up. Furthermore, the improvements were also of clinical importance.CONCLUSIONS: This study provides support for the efficacy of an intervention to reduce body image and eating concerns in midlife women. Further research into interventions tailored for this population is warranted.

psychology, clinical
0019 Body Weight Reduction Following 8-weeks of Time-restricted Eating in Peri- and Postmenopausal Women with Obesity

Leilah Grant,Jennifer Webb,Hailey Bates,Megan Carter,Madeline Dressel,Jonathan Williams,JoAnn Manson,Samia Mora,Hadine Joffe,Shadab Rahman

DOI: https://doi.org/10.1093/sleep/zsae067.0019

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Many women experience weight gain due to hormonal changes during menopause. Time-restricted eating (TRE) has been proposed as a dietary intervention to reduce body weight but has not been studied extensively during the menopause transition. We aimed to test the effect of TRE on body weight and composition in peri- and recently (< 5 yrs) postmenopausal women with obesity. Methods Participants were recruited from the New England area. To date, 23 women (mean age±SD: 51.9±4.1 yrs; mean BMI±SD: 34.9±3.2 kg/m2) have been randomized to 8-weeks of unrestricted eating (URE; n=11) or TRE (n=12), where participants were instructed to consume calories only during a self-selected 8-hour eating window each day (e.g., 10 am-6 pm). Outcomes included body weight, body composition [fat, fat-free and visceral adipose tissue (VAT) mass, measured via dual x-ray absorptiometry], and 7-day caloric intake [kCal/day; per MealloggerTM app with time-stamp]. Change from baseline to post-intervention was compared between the groups using t-tests. Results On average, the TRE eating window was 4.1±0.7 (95%CI 2.7 to 5.6) hours shorter than the URE group (p< 0.001; 7.1±0.2 vs. 11.2±0.7 hours, respectively). Compliance with the daily 8-hour TRE eating window (average compliance 93±6.9% of days) and acceptability (11/12 planned to continue TRE after study completion) were high. Despite no statistically significant between-group difference in calorie intake (1515.8±561.7 vs 1430.0±419.6 kCal/day), the TRE group lost an average of 2.4±0.6 kg (SD), significantly more than the URE group who gained an average of 0.46±0.4 kg (p< 0.01; mean difference=2.8±0.7, 95%CI -4.4 to -1.3). Furthermore, there was a trend toward a greater reduction in fat mass in the TRE (-0.7±0.4 kg) compared to URE group (0.65±0.6 kg) (p=0.059; mean difference=1.4±0.7 kg, 95%CI -2.8 to 0.06). Change in fat-free and VAT mass did not differ. Conclusion In this interim analysis of an ongoing trial, 8 weeks of TRE led to a reduction in body weight and possibly fat mass in peri- and postmenopausal women with obesity. Importantly, compliance and acceptability of the diet were high, suggesting that the intervention is feasible and sustainable in this population. Support (if any) BWH and Bayer Pharmaceuticals supporting U54AG062322; BWH Pollin Research Award; WHAM Edge Award

neurosciences,clinical neurology
Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin

Catherine Duggan,Jean de Dieu Tapsoba,Frank Stanczyk,Ching-Yun Wang,Karen Foster Schubert,Anne McTiernan

DOI: https://doi.org/10.1097/GME.0000000000001250

2019-10-07

Menopause

Abstract:Objective: We tested the effects of weight loss on serum estradiol, estrone, testosterone, and sex hormone-binding globulin ( SHBG ) in overweight/obese women 18 months after completing a year-long, 4-arm, randomized-controlled dietary weight loss and/or exercise trial. Methods: From 2005 to 2008, 439 overweight/obese, postmenopausal women (BMI >25 kg/m 2 ), 50 to 75 years, were randomized to a year-long intervention: diet (reduced calorie, 10% weight loss, N = 118), exercise (225 min/wk moderate-to-vigorous activity, N = 117), combined diet + exercise ( N = 117), or control ( N = 87). At 12 months, 399 women provided blood; of these, 156 returned at 30 months and gave a blood sample. Hormones and SHBG were measured by immunoassay. Changes were compared using generalized estimating equations, adjusting for confounders. Results: At 30 months, participants randomized to the diet + exercise intervention had statistically significant increases in SHBG levels versus controls ( P = 0.001). There was no statistically significant change in SHBG in the exercise or diet intervention arms. Hormone levels did not vary by intervention arm from baseline to 30 months. Participants who maintained weight loss at 30 months had statistically significantly greater decreases in free estradiol and free testosterone ( P trend = 0.02 and P trend = 0.04, respectively) and increases in SHBG ( P trend < 0.0001) versus those who did not have sustained weight loss. Levels of other analytes did not vary by weight loss at 30 months. Conclusions: Sustained weight loss results in reductions in free estradiol and testosterone and increases in SHBG 18-month post-intervention.
Effects of a 12-week exercise-based intervention on weight management in overweight or obese breast cancer survivors: a randomized controlled trial

Fu-Yun Zhao,Jun-E Liu,Xiao-Ming Fang,Lu Chen,Jia-Gui Liang,Yu Liu,Ruo-Lin Li,Hai-Rong Chen

DOI: https://doi.org/10.1007/s00520-023-08300-6

IF: 3.1

2024-01-12

Supportive Care in Cancer

Abstract:Breast cancer survivors face dual challenges: long-term sequelae of treatment and the risk of recurrent disease. Furthermore, obesity and a sedentary lifestyle can complicate both challenges. We aimed to assess the effect of a 12-week exercise-based weight-management program in overweight/obese breast cancer survivors.

oncology,health care sciences & services,rehabilitation
Lifestyle Interventions Targeting Body Weight Changes during the Menopause Transition: A Systematic Review

Janet Jull,Dawn Stacey,Sarah Beach,Alex Dumas,Irene Strychar,Lee-Anne Ufholz,Stephanie Prince,Joseph Abdulnour,Denis Prud’homme

DOI: https://doi.org/10.1155/2014/824310

2014-01-01

Journal of Obesity

Abstract:Objective. To determine the effectiveness of exercise and/or nutrition interventions and to address body weight changes during the menopause transition. Methods. A systematic review of the literature was conducted using electronic databases, grey literature, and hand searching. Two independent researchers screened for studies using experimental designs to evaluate the impact of exercise and/or nutrition interventions on body weight and/or central weight gain performed during the menopausal transition. Studies were quality appraised using Cochrane risk of bias. Included studies were analyzed descriptively. Results. Of 3,564 unique citations screened, 3 studies were eligible (2 randomized controlled trials, and 1 pre/post study). Study quality ranged from low to high risk of bias. One randomized controlled trial with lower risk of bias concluded that participation in an exercise program combined with dietary interventions might mitigate body adiposity increases, which is normally observed during the menopause transition. The other two studies with higher risk of bias suggested that exercise might attenuate weight loss or weight gain and change abdominal adiposity patterns. Conclusions. High quality studies evaluating the effectiveness of interventions targeting body weight changes in women during their menopause transition are needed. Evidence from one higher quality study indicates an effective multifaceted intervention for women to minimize changes in body adiposity.
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors

Wendy Demark-Wahnefried,Graham A. Colditz,Cheryl L. Rock,Rebecca L. Sedjo,Jingxia Liu,Kathleen Y. Wolin,Helen Krontiras,Tim Byers,Bilgé Pakiz,Barbara A. Parker,Michael Naughton,Anthony Elias,Patricia A. Ganz,ENERGY Trial Group,

DOI: https://doi.org/10.1007/s10549-015-3627-5

2015-10-31

Breast Cancer Research and Treatment

Abstract:Obesity is a poor prognostic factor and is negatively related to quality of life (QOL) in breast cancer survivors. Exercise and Nutrition to Enhance Recovery and Good Health for You is the largest weight loss trial completed among cancer survivors. Percent losses in body weight with an intensive group-based intervention versus an attention control were 6.0 versus 1.5 % (p < 0.0001) and 3.7 versus 1.3 % (p < 0.0001) at 12 and 24 months, respectively. ENERGY also was designed to answer the research question: Does weight loss significantly improve vitality and physical function (key components of QOL)? 692 breast cancer survivors (BMI: 25–45 kg/m2) at 4 US sites were randomized to a year-long intensive intervention of 52 group sessions and telephone counseling contacts versus a non-intensive (control) of two in-person counseling sessions. Weight, self-reported QOL, and symptoms were measured semi-annually for two years. Significant decreases in physical function and increases in symptoms were observed among controls from baseline to 6 months, but not in the intervention arm, −3.45 (95 % Confidence Interval [CI] −6.10, −0.79, p = 0.0109) and 0.10 (95 %CI 0.04, 0.16, p = 0.0021), respectively. Improvements in vitality were seen in both arms but trended toward greater improvement in the intervention arm −2.72 (95 % CI −5.45, 0.01, p = 0.0508). These differences diminished over time; however, depressive symptoms increased in the intervention versus control arms and became significant at 24 months, −1.64 (95 % CI −3.13, −0.15, p = 0.0308). Increased QOL has been reported in shorter term diet and exercise trials among cancer survivors. These longer term data suggest that diet and exercise interventions improve some aspects of QOL, but these benefits may diminish over time.

oncology
Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT

Michael Hettchen,Simon von Stengel,Matthias Kohl,Marie H Murphy,Mahdieh Shojaa,Mansour Ghasemikaram,Laura Bragonzoni,Francesco Benvenuti,Claudio Ripamonti,Maria Grazia Benedetti,Mikko Julin,Tapani Risto,Wolfgang Kemmler

DOI: https://doi.org/10.2147/CIA.S283177

2021-01-11

Abstract:The menopausal transition is a critical period in women's lives. Exercise might be the most promising non-pharmaceutic intervention to address the large variety of risk factors related to the pronounced estradiol decline during peri- and early-postmenopause. The aim of this study was to determine the effect of an 18-month multipurpose exercise program on risk factors and symptoms related to the menopausal transition. Fifty-four women 1-5 years postmenopause with osteopenia or osteoporosis were randomly assigned 1) to a high impact weight-bearing/high-intensity/velocity resistance training group (EG: n=27) exercising three times a week or 2) to an attendance control group (CG: n=27) that performed low-intensity exercise once a week. Both groups were supplemented with cholecalciferol and calcium. The primary study endpoint was bone mineral density (BMD) at lumbar spine (LS) and total hip, secondary outcomes were lean body mass (LBM), total and abdominal body percentage, metabolic syndrome Z-Score (MetS-Z), menopausal symptoms and muscle strength and power. Due to COVID-19, the study was stopped after 13 months. We observed significant effects for BMD-LS (EG: 0.002±.018 versus CG: -.009±0.018 mg/cm2, p=0.027) but not for BMD total hip (EG: -0.01±.016 versus CG: -.009±0.020 mg/cm2, p=0.129). LBM improved significantly in the EG and decreased in the CG (0.39±1.08 vs -0.37±1.34 kg, p=0.026). Total and abdominal body fat improved significantly in the EG and was maintained in the CG (-1.44±1.49 vs -0.02±1.55 kg, p=0.002 and -1.50±2.33 vs 0.08±2.07 kg, p=0.011). Significant effects in favor of the EG were also determined for menopausal symptoms (p=0.029), hip/leg extension strength (p<0.001) and power (p<0.001). However, changes of the MetS-Z did not differ significantly (p=0.149) between EG and CG. In summary, with minor exceptions, we demonstrated the effectiveness of a multipurpose exercise protocol dedicated to early-postmenopausal women on various risk factors and complaints related to the menopausal transition.
Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study

Karen M. Basen-Engquist,Margaret Raber,Cindy L. Carmack,Banu Arun,Abenaa M. Brewster,Michelle Fingeret,Susan M. Schembre,Carol Harrison,Heidi Y Perkins,Yisheng Li,Jaejoon Song,Minxing Chen,James L. Murray

DOI: https://doi.org/10.1007/s00520-020-05411-2

IF: 3.1

2020-04-05

Supportive Care in Cancer

Abstract:PurposeWeight gain is common among breast cancer patients and may contribute to poorer treatment outcomes. Most programs target breast cancer survivors after the completion of therapy and focus on weight reduction. This study examined the feasibility and preliminary efficacy of an intervention designed to prevent primary weight gain among women receiving neoadjuvant chemotherapy for breast cancer.MethodsThirty-eight newly diagnosed stage II or III breast cancer patients were randomized to the BALANCE intervention or usual care within 3 weeks of starting neoadjuvant chemotherapy. The intervention used a size acceptance-based approach and encouraged home-based resistance and moderate-intensity aerobic exercise as well as a low energy-dense diet to prevent weight gain. Assessments were conducted at baseline, mid-chemotherapy (3 months), and post-chemotherapy (6 months). Intervention feasibility, acceptability, and preliminary effects on anthropometric, quality of life, and circulating biomarker measures were evaluated.ResultsIntervention participant retention (100%) and in-person session attendance (80%) were high during the intervention period, although attendance dropped to 43% for telephone-delivered sessions. The majority of participants reported being satisfied with the intervention during chemotherapy (88%). Participants in the intervention group had greater reductions in waist circumference (p = .03) and greater improvements in self-reported vitality scores (p = .03) than the control group at the end of chemotherapy. Significant effects on biomarkers were not observed.ConclusionsA size acceptance weight management program is feasible during neoadjuvant chemotherapy among breast cancer patients and may have beneficial effects on waist circumference and patient vitality.Trial registrationThis study was registered as a clinical trial at www.clinicaltrials.gov (NCT00533338).

oncology,health care sciences & services,rehabilitation
The Role of Exercise Self-Efficacy in Exercise Participation Among Women With Persistent Fatigue After Breast Cancer: A Mixed-Methods Study

Stephen Wechsler,Mei R Fu,Kathleen Lyons,Kelley C Wood,Lisa J Wood Magee

DOI: https://doi.org/10.1093/ptj/pzac143

2022-10-12

Physical Therapy

Abstract:Abstract Objective Survivors of breast cancer with persistent cancer-related fatigue (CRF) report less exercise participation compared with survivors of breast cancer without CRF. Although CRF predicts other domains of self-efficacy among survivors, the effect of CRF on exercise self-efficacy (ESE)—an important predictor of exercise participation—has not been quantified. This study examined the relationship between CRF, ESE, and exercise participation and explored the lived experience of engaging in exercise among survivors of breast cancer with persistent CRF. Methods Fifty-eight survivors of breast cancer (3.7 [SD = 2.4] years after primary treatment) self-reported CRF, ESE, and exercise participation (hours of moderate-intensity exercise per week). Regression and mediation analyses were conducted. Survivors who reported clinically significant CRF and weekly exercise were purposively sampled for 1-on-1 interviews (N = 11). Thematic analysis was performed across participants and within higher versus lower ESE subsets. Results Greater CRF predicted lower ESE (β = −0.32) and less exercise participation (β = −0.08). ESE mediated the relationship between CRF and exercise participation (β = −0.05, 95% CI = −0.09 to −0.02). Qualitative data showed that survivors of breast cancer with higher ESE perceived exercise as a strategy to manage fatigue, described self-motivation and commitment to exercise, and had multiple sources of support. In contrast, survivors with lower ESE described less initiative to manage fatigue through exercise, greater difficulty staying committed to exercise, and less support. Conclusions Survivors of breast cancer with persistent CRF may experience decreased ESE, which negatively influences exercise participation. Clinicians should screen for or discuss confidence as it relates to exercise and consider tailoring standardized exercise recommendations for this population to optimize ESE. This may facilitate more sustainable exercise participation and improve outcomes. Impact This study highlights the behavioral underpinnings of CRF as a barrier to exercise. Individualized exercise tailored to optimize ESE may facilitate sustainable exercise participation among survivors of breast cancer with CRF. Strategies for clinicians to address ESE are described and future research is suggested. Lay Summary Women with fatigue after breast cancer treatment may have lower confidence about their ability to engage in exercise. Individually tailoring exercise to build confidence as it relates to exercise may result in more consistent exercise and better health-related outcomes.

rehabilitation,orthopedics
Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients.

K. Akioka,M. Okamoto,K. Nakamura,H. Ushigome,Y. Kadotani,Y. Ohmori,N. Yoshimura

DOI: https://doi.org/10.1016/S0041-1345(02)03918-0

IF: 1.014

2003-02-01

Transplantation Proceedings

Abstract:
Moderate-Intensity Continuous Training or High-Intensity Interval Training with or without Resistance Training for Altering Body Composition in Postmenopausal Women

Marine Dupuit,Mélanie Rance,Claire Morel,Patrice Bouillon,Bruno Pereira,Alban Bonnet,Florie Maillard,Martine Duclos,Nathalie Boisseau,MARINE DUPUIT,MÉLANIE RANCE,CLAIRE MOREL,PATRICE BOUILLON,BRUNO PEREIRA,ALBAN BONNET,FLORIE MAILLARD,MARTINE DUCLOS,NATHALIE BOISSEAU

DOI: https://doi.org/10.1249/mss.0000000000002162

2019-09-13

Abstract:<span>Purpose This study aimed to compare body composition changes induced by moderate-intensity continuous training (MICT), high-intensity interval training (HIIT), or HIIT + resistance training (RT) programs (3 d·wk−1, 12 wk) in overweight/obese postmenopausal women, and to determine whether fat mass reduction is related to greater fat oxidation (FatOx).Methods Participants (n = 27) were randomized in three groups: MICT (40 min at 55%–60% of peak power output), HIIT (60 × 8 s at 80%–90% of peak HR, 12 s active recovery), and HIIT + RT (HIIT + 8 whole-body exercises: 1 set of 8–12 repetitions). Dual-energy x-ray absorptiometry was used to measure whole-body and abdominal/visceral fat mass (FM) and fat-free mass. FatOx was determined at rest, during a moderate-intensity exercise (40 min at 50% of peak power output), and for 20 min postexercise, before and after training.Results Overall, energy intake and physical activity levels did not vary from the beginning to the end of the intervention. Body weight and total FM decreased in all groups over time, but significant abdominal/visceral FM losses were observed only in HIIT and HIIT + RT groups. When expressed in percentage, total FM, fat-free mass, and muscle mass were significantly modified only by HIIT + RT training. FatOx did not change at rest but increased similarly in the three groups during and after exercise. Therefore, the HIIT-induced greater FM loss was not related to higher FatOx during or after exercise.Conclusions MICT or HIIT ± RT could be proposed to nondieting postmenopausal women who are overweight/obese to decrease weight and whole-body FM. The HIIT programs were more effective than MICT in reducing abdominal/visceral FM. RT addition did not potentiate this effect but increased the percentage of muscle mass.</span>

sport sciences
Exercise interventions for self-perceived body image, self-esteem and self-efficacy in women diagnosed with breast cancer: a systematic review with meta-analysis and meta-regressions

María Jesús Casuso-Holgado,Javier Martinez-Calderon,Patricia Martínez-Miranda,María Jesús Muñoz-Fernández,Carlos Bernal-Utrera,Cristina García-Muñoz

DOI: https://doi.org/10.1007/s00520-024-08874-9

IF: 3.1

2024-09-20

Supportive Care in Cancer

Abstract:To synthesise the effectiveness of exercise interventions on self-perceived body image, self-esteem and self-efficacy in women diagnosed with breast cancer who are undergoing or have completed primary adjuvant treatments.

oncology,health care sciences & services,rehabilitation
Effect of Self-Efficacy on Weight Loss: A Psychosocial Analysis of a Community-Based Adaptation of the Diabetes Prevention Program Lifestyle Intervention

Laura M. Hays,Emily A. Finch,Chandan Saha,David G. Marrero,Ronald T. Ackermann

DOI: https://doi.org/10.2337/diaspect.27.4.270

2014-11-01

Diabetes Spectrum

Abstract:Objective. Weight loss is the most effective approach to reducing diabetes risk. It is a research priority to identify factors that may enhance weight loss success, particularly among those at risk for diabetes. This analysis explored the relationships between self-efficacy, weight loss, and dietary fat intake among adults at risk for developing type 2 diabetes. Methods. This pilot, site-randomized trial was designed to compare group-based Diabetes Prevention Program lifestyle intervention delivery by YMCA staff to brief counseling alone (control) in 92 adults at risk for diabetes (BMI ≥ 24 kg/m2, ≥ 2 diabetes risk factors, and a random capillary blood glucose of 110–199 mg/dl). Self-efficacy was measured using the Weight Efficacy Lifestyle questionnaire. Data were collected at baseline, 6 months, and 12 months. A paired t test was used to determine within-group changes in self-efficacy and weight at 6 and 12 months. Using a fitted model, we estimated how much of an increase in self-efficacy was related to a 5% weight reduction at 6 and 12 months. Results. Self-efficacy was associated with a 5% reduction in baseline weight at 6 and 12 months but was not related to fat intake. Conclusion. These findings suggest that it is important to assess the level of self-efficacy when counseling adults at high risk for diabetes about weight loss. Certain aspects of self-efficacy seem to play a greater role, depending on the stage of weight loss.
Theory-Driven Behavioral Obesity Treatment and Carry-Over of Exercise-Related, to Eating-Related, Self-Regulation: Effects on Short- and Long-Term Weight/Waist Circumference Reductions

James J. Annesi

DOI: https://doi.org/10.1177/10901981241281331

2024-09-29

Health Education & Behavior

Abstract:Health Education &Behavior, Ahead of Print. The predominant method for treating obesity has been suggesting and providing information on a controlled diet and, to a lesser extent, increased exercise. That approach has largely failed beyond the short term for many decades as obesity rates continue to rise. Therefore, leveraging improvements in psychosocial correlates of weight-loss behaviors has sometimes been suggested instead. The aim of this study was evaluation of targeted improvements in self-regulation and self-efficacy within a theoretically derived weight-loss program. Women with obesity (N = 103) participated in a year-long community-based program emphasizing self-regulatory skills development to counter lifestyle barriers/challenges to first exercise, then controlled eating. Within a structured treatment protocol administered by community facility employees–and based on tenets of social cognitive theory, self-regulation theory, self-efficacy theory, and coaction theory–self-regulatory skills were initially developed to foster adherence to exercise. Those skills were then adapted to promote eating-behavior changes, emphasizing fruit and vegetable intake. Improvements in measures of exercise self-regulation, eating self-regulation, and self-efficacy for controlling eating, their corresponding behaviors, and weight and waist circumference were significant. Greater within-participant carry-over of changes in exercise self-regulation to eating self-regulation was significantly associated with more weight and waist circumference reductions over both 6 and 12 months. Change in eating-related self-efficacy significantly mediated those relationships. The mean weight reduction of approximately 6% indicated positive effects on obesity-related health risks. The community-based setting indicated potentials for large-scale dissemination of theory- and evidence-driven behavioral obesity treatments focused primarily on self-regulatory skills development.

public, environmental & occupational health
Uncontrolled pilot study of an Acceptance and Commitment Therapy and Health at Every Size intervention for obese, depressed women: Accept Yourself!

Margit I. Berman,Stephanie N. Morton,Mark T. Hegel

DOI: https://doi.org/10.1037/pst0000083

2016-12-01

Psychotherapy

Abstract:Depression and obesity frequently co-occur, but providing adequate treatment to depressed obese women is challenging because existing treatments for each problem in isolation are suboptimal, and treatments to address one problem may exacerbate the other. This study used an uncontrolled, pretreatment-to-posttreatment design, with 3-month follow-up, to evaluate the feasibility and outcome of a novel, self-acceptance-based treatment for obese women with depression, "Accept Yourself!" Accept Yourself! is an 11-week manualized, group-based intervention that integrates Health At Every Size (an evidence-based paradigm to enhance physical health) and Acceptance and Commitment Therapy (an evidence-based psychotherapy often used to treat depression and eating-related concerns) to improve the physical and mental health of obese, depressed women without encouraging weight loss. Twenty-one obese women with Major Depressive Disorder received the intervention; 18 completed at least seven sessions, a minimal dose of the intervention. Depressive symptoms, depression diagnosis, physical health outcomes (including physical activity and blood pressure), and obesity-related quality of life were assessed at baseline, posttreatment, and 3-month follow-up. Weight was also monitored. Depression, blood pressure, and obesity-related quality of life significantly improved from pretreatment to posttreatment, and improvements were sustained over a 3-month follow-up. Participants did not gain significant weight during the intervention or at follow-up. These data, although preliminary and nonexperimental, suggest that Accept Yourself! could be a promising treatment for obese, depressed women, and support the value of larger randomized controlled trials. (PsycINFO Database Record

psychology, clinical

Self-Efficacy Targeted Treatments for Weight Loss in Postmenopausal Women

Self-regulatory and self-efficacy mechanisms of weight loss in women within a community-based behavioral obesity treatment

Weight Loss and the Prevention of Weight Regain: Evaluation of a Treatment Model of Exercise Self-Regulation Generalizing to Controlled Eating

Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

Pharmacologic Therapy To Induce Weight Loss In Women Who Have Obesity/Overweight With Polycystic Ovary Syndrome: A Systematic Review And Network Meta-Analysis

Evaluating the effect of targeting body shape concerns on long-term weight change

A body image and disordered eating intervention for women in midlife: A randomized controlled trial.

0019 Body Weight Reduction Following 8-weeks of Time-restricted Eating in Peri- and Postmenopausal Women with Obesity

Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin

Effects of a 12-week exercise-based intervention on weight management in overweight or obese breast cancer survivors: a randomized controlled trial

Lifestyle Interventions Targeting Body Weight Changes during the Menopause Transition: A Systematic Review

Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors

Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT

Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study

The Role of Exercise Self-Efficacy in Exercise Participation Among Women With Persistent Fatigue After Breast Cancer: A Mixed-Methods Study

Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients.

Moderate-Intensity Continuous Training or High-Intensity Interval Training with or without Resistance Training for Altering Body Composition in Postmenopausal Women

Exercise interventions for self-perceived body image, self-esteem and self-efficacy in women diagnosed with breast cancer: a systematic review with meta-analysis and meta-regressions

Effect of Self-Efficacy on Weight Loss: A Psychosocial Analysis of a Community-Based Adaptation of the Diabetes Prevention Program Lifestyle Intervention

Theory-Driven Behavioral Obesity Treatment and Carry-Over of Exercise-Related, to Eating-Related, Self-Regulation: Effects on Short- and Long-Term Weight/Waist Circumference Reductions

Uncontrolled pilot study of an Acceptance and Commitment Therapy and Health at Every Size intervention for obese, depressed women: Accept Yourself!